Martin Sarter - Publications

Affiliations: 
Psychology University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
acetylcholine, attention, basal forebrain
Website:
https://sites.lsa.umich.edu/msarter/

249 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Avila C, Kucinski A, Sarter M. Complex movement control in a rat model of Parkinsonian falls: bidirectional control by striatal cholinergic interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32554512 DOI: 10.1523/JNEUROSCI.0220-20.2020  0.4
2020 Sarter M, Lustig C. Forebrain Cholinergic Signaling: Wired and Phasic, Not Tonic, and Causing Behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 40: 712-719. PMID 31969489 DOI: 10.1523/JNEUROSCI.1305-19.2019  0.68
2020 Phillips KB, Sarter M. Addiction vulnerability and the processing of significant cues: Sign-, but not goal-, tracker perceptual sensitivity relies on cue salience. Behavioral Neuroscience. PMID 31916796 DOI: 10.1037/bne0000353  0.32
2019 Cherian AK, Kucinski A, Wu R, de Jong IEM, Sarter M. Correction to: Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease. Psychopharmacology. PMID 31650233 DOI: 10.1007/s00213-019-05375-0  0.4
2019 Kucinski A, Phillips KB, Koshy Cherian A, Sarter M. Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071. Psychopharmacology. PMID 31620809 DOI: 10.1007/s00213-019-05354-5  0.56
2019 Koshy Cherian A, Tronson NC, Parikh V, Kucinski A, Blakely RD, Sarter M. Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+/- mice. Behavioral Neuroscience. PMID 30896190 DOI: 10.1037/bne0000310  0.68
2019 Sarter M, Lustig C. Cholinergic double duty: cue detection and attentional control. Current Opinion in Psychology. 29: 102-107. PMID 30711909 DOI: 10.1016/j.copsyc.2018.12.026  0.68
2019 Kucinski A, Kim Y, Sarter M. Basal forebrain chemogenetic inhibition disrupts the superior complex movement control of goal-tracking rats. Behavioral Neuroscience. 133: 121-134. PMID 30688488 DOI: 10.1037/bne0000290  0.4
2019 Koshy Cherian A, Kucinski A, Wu R, de Jong IEM, Sarter M. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease. Psychopharmacology. PMID 30607479 DOI: 10.1007/s00213-018-5150-y  0.56
2018 Albin RL, Surmeier DJ, Tubert C, Sarter M, Müller MLTM, Bohnen NI, Dauer WT. Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30398673 DOI: 10.1002/mds.27540  0.4
2018 Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/cne.24541  0.4
2018 Pitchers KK, Sarter M, Robinson TE. The hot 'n' cold of cue-induced drug relapse. Learning & Memory (Cold Spring Harbor, N.Y.). 25: 474-480. PMID 30115769 DOI: 10.1101/lm.046995.117  0.32
2018 Kucinski A, Lustig C, Sarter M. Addiction vulnerability trait impacts complex movement control: Evidence from sign-trackers. Behavioural Brain Research. PMID 29705686 DOI: 10.1016/j.bbr.2018.04.045  0.68
2018 Sarter M, Phillips KB. The Neuroscience of Cognitive-Motivational Styles: Sign- and Goal-Trackers as Animal Models. Behavioral Neuroscience. PMID 29355335 DOI: 10.1037/bne0000226  0.32
2017 Kim K, Müller MLTM, Bohnen NI, Sarter M, Lustig C. The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease. Neuroimage. PMID 29277400 DOI: 10.1016/j.neuroimage.2017.12.012  0.68
2017 Pitchers KK, Kane LF, Kim Y, Robinson TE, Sarter M. "Hot" versus "cold" behavioral-cognitive styles: Motivational-dopaminergic versus cognitive-cholinergic processing of a Pavlovian cocaine cue in sign- and goal-tracking rats. The European Journal of Neuroscience. PMID 29044780 DOI: 10.1111/ejn.13741  0.32
2017 Pitchers KK, Phillips KB, Jones JL, Robinson TE, Sarter M. Diverse roads to relapse: A discriminative cue signaling cocaine availability is more effective in renewing cocaine-seeking in goal-trackers than sign-trackers, and depends on basal forebrain cholinergic activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28659281 DOI: 10.1523/JNEUROSCI.0990-17.2017  0.32
2017 Koshy Cherian A, Parikh V, Wu Q, Mao-Draayer Y, Wang Q, Blakely RD, Sarter M. Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity. Neurochemistry International. PMID 28577989 DOI: 10.1016/j.neuint.2017.05.022  0.68
2017 Berry AS, Sarter M, Lustig C. Distinct Frontoparietal Networks Underlying Attentional Effort and Cognitive Control. Journal of Cognitive Neuroscience. 1-14. PMID 28253080 DOI: 10.1162/jocn_a_01112  0.68
2017 Howe WM, Gritton HJ, Lusk N, Roberts EA, Hetrick VL, Berke JD, Sarter M. Acetylcholine release in prefrontal cortex promotes gamma oscillations and theta-gamma coupling during cue detection. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28213446 DOI: 10.1523/JNEUROSCI.2737-16.2017  0.96
2017 Koshy Cherian A, Kucinski A, Pitchers K, Yegla B, Parikh V, Kim Y, Valuskova P, Gurnani S, Lindsley CW, Blakely RD, Sarter M. Unresponsive choline transporter as a trait neuromarker and a causal mediator of bottom-up attentional biases. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28193693 DOI: 10.1523/JNEUROSCI.3499-16.2017  0.68
2017 Kim K, Müller ML, Bohnen NI, Sarter M, Lustig C. Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's Disease patients with defined cholinergic losses. Neuroimage. PMID 28167350 DOI: 10.1016/j.neuroimage.2017.02.006  0.68
2016 Pitchers KK, Wood TR, Skrzynski CJ, Robinson TE, Sarter M. The ability for cocaine and cocaine-associated cues to compete for attention. Behavioural Brain Research. PMID 27890441 DOI: 10.1016/j.bbr.2016.11.024  0.32
2016 Kucinski A, de Jong IE, Sarter M. Reducing falls in Parkinson's disease: Interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements. The European Journal of Neuroscience. PMID 27469080 DOI: 10.1111/ejn.13354  1
2016 Lustig C, Sarter M. Attention and the Cholinergic System: Relevance to Schizophrenia. Current Topics in Behavioral Neurosciences. PMID 27418070 DOI: 10.1007/7854_2015_5009  0.68
2016 Sarter M, Lustig C, Blakely RD, Cherian AK. Cholinergic genetics of visual attention: human and mouse choline transporter capacity variants influence distractibility. Journal of Physiology, Paris. PMID 27404793 DOI: 10.1016/j.jphysparis.2016.07.001  0.68
2016 Sarter M, Lustig C, Berry AS, Gritton H, Howe WM, Parikh V. What do phasic cholinergic signals do? Neurobiology of Learning and Memory. 130: 135-141. PMID 26911787 DOI: 10.1016/j.nlm.2016.02.008  1
2016 Gritton HJ, Howe WM, Mallory CS, Hetrick VL, Berke JD, Sarter M. Cortical cholinergic signaling controls the detection of cues. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787867 DOI: 10.1073/pnas.1516134113  0.96
2015 Kucinski A, Sarter M. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline. Behavioral Neuroscience. 129: 96-104. PMID 25798629 DOI: 10.1037/bne0000048  1
2015 Kucinski A, Albin RL, Lustig C, Sarter M. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behavioural Brain Research. 282: 155-64. PMID 25595423 DOI: 10.1016/j.bbr.2015.01.012  1
2015 Berry AS, Blakely RD, Sarter M, Lustig C. Cholinergic capacity mediates prefrontal engagement during challenges to attention: evidence from imaging genetics. Neuroimage. 108: 386-95. PMID 25536497 DOI: 10.1016/j.neuroimage.2014.12.036  1
2015 Sarter M, Kim Y. Interpreting chemical neurotransmission in vivo: techniques, time scales, and theories. Acs Chemical Neuroscience. 6: 8-10. PMID 25514622 DOI: 10.1021/cn500319m  1
2015 Pitchers KK, Flagel SB, O'Donnell EG, Woods LC, Sarter M, Robinson TE. Individual variation in the propensity to attribute incentive salience to a food cue: influence of sex. Behavioural Brain Research. 278: 462-9. PMID 25446811 DOI: 10.1016/j.bbr.2014.10.036  1
2015 Sarter M. Behavioral-cognitive targets for cholinergic enhancement Current Opinion in Behavioral Sciences. 4: 22-26. DOI: 10.1016/j.cobeha.2015.01.004  1
2014 Bohnen N, Sarter M, Muller M, Dauer W, Albin R. Author response. Neurology. 82: 1568-9. PMID 24895748 DOI: 10.1212/WNL.0000000000000607  1
2014 Sarter M, Albin RL, Kucinski A, Lustig C. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Experimental Neurology. 257: 120-9. PMID 24805070 DOI: 10.1016/j.expneurol.2014.04.032  1
2014 Berry AS, Demeter E, Sabhapathy S, English BA, Blakely RD, Sarter M, Lustig C. Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. Journal of Cognitive Neuroscience. 26: 1981-91. PMID 24666128 DOI: 10.1162/jocn_a_00607  1
2014 Koshy Cherian A, Gritton H, Johnson DE, Young D, Kozak R, Sarter M. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Neuropharmacology. 82: 41-8. PMID 24647121 DOI: 10.1016/j.neuropharm.2014.03.004  1
2014 Sarter M, Lustig C, Howe WM, Gritton H, Berry AS. Deterministic functions of cortical acetylcholine. The European Journal of Neuroscience. 39: 1912-20. PMID 24593677 DOI: 10.1111/ejn.12515  1
2014 Holmstrand EC, Lund D, Cherian AK, Wright J, Martin RF, Ennis EA, Stanwood GD, Sarter M, Blakely RD. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Neurochemistry International. 73: 217-28. PMID 24274995 DOI: 10.1016/j.neuint.2013.11.008  1
2014 Fritschy JM, Sarter M. Editor's issue European Journal of Neuroscience. 39: 1719. DOI: 10.1111/ejn.12605  1
2014 Fritschy JM, Sarter M, Joëls M. Ferdinando Rossi (1960-2014) European Journal of Neuroscience. DOI: 10.1111/ejn.12530  1
2013 Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16522-39. PMID 24133257 DOI: 10.1523/JNEUROSCI.2545-13.2013  1
2013 Grupe M, Paolone G, Jensen AA, Sandager-Nielsen K, Sarter M, Grunnet M. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats. Biochemical Pharmacology. 86: 1487-96. PMID 24051136 DOI: 10.1016/j.bcp.2013.09.005  1
2013 Paolone G, Mallory CS, Koshy Cherian A, Miller TR, Blakely RD, Sarter M. Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits. Neuropharmacology. 75: 274-85. PMID 23958450 DOI: 10.1016/j.neuropharm.2013.07.032  1
2013 Howe WM, Berry AS, Francois J, Gilmour G, Carp JM, Tricklebank M, Lustig C, Sarter M. Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 8742-52. PMID 23678117 DOI: 10.1523/JNEUROSCI.5809-12.2013  1
2013 Paolone G, Angelakos CC, Meyer PJ, Robinson TE, Sarter M. Cholinergic control over attention in rats prone to attribute incentive salience to reward cues. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 8321-35. PMID 23658172 DOI: 10.1523/JNEUROSCI.0709-13.2013  1
2013 Gritton HJ, Stasiak AM, Sarter M, Lee TM. Cognitive performance as a zeitgeber: cognitive oscillators and cholinergic modulation of the SCN entrain circadian rhythms. Plos One. 8: e56206. PMID 23441168 DOI: 10.1371/journal.pone.0056206  1
2013 Parikh V, St Peters M, Blakely RD, Sarter M. The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2326-37. PMID 23392663 DOI: 10.1523/JNEUROSCI.4993-12.2013  1
2013 Demeter E, Guthrie SK, Taylor SF, Sarter M, Lustig C. Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task. Schizophrenia Research. 144: 136-41. PMID 23374860 DOI: 10.1016/j.schres.2013.01.003  1
2013 Parikh V, Howe WM, Welchko RM, Naughton SX, D'Amore DE, Han DH, Deo M, Turner DL, Sarter M. Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging. The European Journal of Neuroscience. 37: 278-93. PMID 23228124 DOI: 10.1111/ejn.12090  1
2013 Demeter E, Sarter M. Leveraging the cortical cholinergic system to enhance attention. Neuropharmacology. 64: 294-304. PMID 22796110 DOI: 10.1016/j.neuropharm.2012.06.060  1
2013 Lustig C, Kozak R, Sarter M, Young JW, Robbins TW. CNTRICS final animal model task selection: control of attention. Neuroscience and Biobehavioral Reviews. 37: 2099-110. PMID 22683929 DOI: 10.1016/j.neubiorev.2012.05.009  1
2013 Parikh V, Sarter M. Forebrain cholinergic systems and cognition: New insights based on rapid detection of choline spikes using enzyme-based biosensors Neuromethods. 80: 257-277. DOI: 10.1007/978-1-62703-370-1-12  1
2012 Paolone G, Lee TM, Sarter M. Time to pay attention: attentional performance time-stamped prefrontal cholinergic activation, diurnality, and performance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12115-28. PMID 22933795 DOI: 10.1523/JNEUROSCI.2271-12.2012  1
2012 Brooks JM, Pershing ML, Thomsen MS, Mikkelsen JD, Sarter M, Bruno JP. Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2476-86. PMID 22781844 DOI: 10.1038/npp.2012.106  1
2012 Fritschy JM, Sarter M. Early brain repair and protection. The European Journal of Neuroscience. 35: 1810. PMID 22708591 DOI: 10.1111/j.1460-9568.2012.08173.x  1
2012 Sarter M, Tricklebank M. Revitalizing psychiatric drug discovery. Nature Reviews. Drug Discovery. 11: 423-4. PMID 22653200 DOI: 10.1038/nrd3755  1
2012 Gritton HJ, Kantorowski A, Sarter M, Lee TM. Bidirectional interactions between circadian entrainment and cognitive performance. Learning & Memory (Cold Spring Harbor, N.Y.). 19: 126-41. PMID 22383380 DOI: 10.1101/lm.023499.111  1
2012 Luck SJ, Ford JM, Sarter M, Lustig C. CNTRICS final biomarker selection: Control of attention. Schizophrenia Bulletin. 38: 53-61. PMID 21765166 DOI: 10.1093/schbul/sbr065  1
2012 Sarter M, Lustig C, Taylor SF. Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology. 62: 1544-53. PMID 21156184 DOI: 10.1016/j.neuropharm.2010.12.001  1
2012 Peters MS, Sarter M. Cognitive enhancers versus stimulants Sleep Deprivation, Stimulant Medications, and Cognition. 136-151. DOI: 10.1017/CBO9780511783005.012  1
2011 Sarter M, Paolone G. Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches. Behavioral Neuroscience. 125: 825-35. PMID 22122146 DOI: 10.1037/a0026227  1
2011 St Peters M, Cherian AK, Bradshaw M, Sarter M. Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP). Behavioural Brain Research. 225: 574-83. PMID 21888929 DOI: 10.1016/j.bbr.2011.08.025  1
2011 Brooks JM, Sarter M, Bruno JP. Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2477-87. PMID 21814184 DOI: 10.1038/npp.2011.136  1
2011 Fritschy JM, Sarter M. Why would you pay to get published? The European Journal of Neuroscience. 34: 1-2. PMID 21722204 DOI: 10.1111/j.1460-9568.2011.07752.x  1
2011 St Peters M, Demeter E, Lustig C, Bruno JP, Sarter M. Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9760-71. PMID 21715641 DOI: 10.1523/JNEUROSCI.1902-11.2011  1
2011 Demeter E, Hernandez-Garcia L, Sarter M, Lustig C. Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage. 54: 1518-29. PMID 20851189 DOI: 10.1016/j.neuroimage.2010.09.026  1
2011 Hasselmo ME, Sarter M. Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 52-73. PMID 20668433 DOI: 10.1038/npp.2010.104  1
2011 Fritschy JM, Sarter M. EJN in the digital age: Introducing the 'EJN blog' European Journal of Neuroscience. 34: 1711. DOI: 10.1111/j.1460-9568.2011.07945.x  1
2010 Fritschy JM, Sarter M. Editorial. The European Journal of Neuroscience. 31: 2123. PMID 20529128 DOI: 10.1111/j.1460-9568.2010.07288.x  1
2010 Parikh V, Ji J, Decker MW, Sarter M. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 3518-30. PMID 20203212 DOI: 10.1523/JNEUROSCI.5712-09.2010  1
2010 Howe WM, Ji J, Parikh V, Williams S, Mocaër E, Trocmé-Thibierge C, Sarter M. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1391-401. PMID 20147893 DOI: 10.1038/npp.2010.9  1
2010 Sarter M, Lustig C. Attentional Functions in Learning and Memory Encyclopedia of Neuroscience. 639-645. DOI: 10.1016/B978-008045046-9.00747-6  1
2009 Gritton HJ, Sutton BC, Martinez V, Sarter M, Lee TM. Interactions between cognition and circadian rhythms: attentional demands modify circadian entrainment. Behavioral Neuroscience. 123: 937-48. PMID 19824760 DOI: 10.1037/a0017128  1
2009 Alexander KS, Brooks JM, Sarter M, Bruno JP. Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2710-20. PMID 19693002 DOI: 10.1038/npp.2009.105  1
2009 Broussard JI, Karelina K, Sarter M, Givens B. Cholinergic optimization of cue-evoked parietal activity during challenged attentional performance. The European Journal of Neuroscience. 29: 1711-22. PMID 19419433 DOI: 10.1111/j.1460-9568.2009.06713.x  1
2009 Sarter M, Parikh V, Howe WM. nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. Biochemical Pharmacology. 78: 658-67. PMID 19406107 DOI: 10.1016/j.bcp.2009.04.019  1
2009 Sarter M, Parikh V, Howe WM. Phasic acetylcholine release and the volume transmission hypothesis: time to move on. Nature Reviews. Neuroscience. 10: 383-90. PMID 19377503 DOI: 10.1038/nrn2635  1
2009 Fritschy JM, Sarter M. Repeated massage-like stimulation induces long-term effects on nociception: contribution of oxytocinergic mechanisms. The European Journal of Neuroscience. 29: 868. PMID 19250442 DOI: 10.1111/j.1460-9568.2009.06687.x  1
2009 Saper CB, Maunsell JHR, Destexhe A, Richmond B, Campagnoni A, Sarter M, Fritschy JM, Bloom FE, Perry G, Smith MA, Ascoli G, Kennedy D, De Schutter E, Eichenbaum H, Greenamyre JT, et al. The neuroscience peer review consortium Journal of Neuroscience. 29: 1255-1256. PMID 19193872  1
2009 Nuechterlein KH, Luck SJ, Lustig C, Sarter M. CNTRICS final task selection: control of attention. Schizophrenia Bulletin. 35: 182-96. PMID 19074499 DOI: 10.1093/schbul/sbn158  1
2009 Sarter M, Martinez V, Kozak R. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology. 202: 237-58. PMID 18618100 DOI: 10.1007/s00213-008-1216-6  1
2008 Sarter M, Fritschy JM. Reporting statistical methods and statistical results in EJN. The European Journal of Neuroscience. 28: 2363-4. PMID 19087166 DOI: 10.1111/j.1460-9568.2008.06581.x  1
2008 Demeter E, Sarter M, Lustig C. Rats and humans paying attention: cross-species task development for translational research. Neuropsychology. 22: 787-99. PMID 18999353 DOI: 10.1037/a0013712  1
2008 Freed C, Martinez V, Sarter M, DeVries C, Bergdall V. Operant task performance and corticosterone concentrations in rats housed directly on bedding and on wire. Journal of the American Association For Laboratory Animal Science : Jaalas. 47: 18-22. PMID 18947165  1
2008 Fritschy JM, Sarter M. What is in store for EJN? The European Journal of Neuroscience. 28: 1047. PMID 18823501 DOI: 10.1111/j.1460-9568.2008.06469.x  1
2008 Parikh V, Sarter M. Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Annals of the New York Academy of Sciences. 1129: 225-35. PMID 18591483 DOI: 10.1196/annals.1417.021  1
2008 Parikh V, Man K, Decker MW, Sarter M. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 3769-80. PMID 18385335 DOI: 10.1523/JNEUROSCI.5251-07.2008  1
2008 Giuliano C, Parikh V, Ward JR, Chiamulera C, Sarter M. Increases in cholinergic neurotransmission measured by using choline-sensitive microelectrodes: enhanced detection by hydrolysis of acetylcholine on recording sites? Neurochemistry International. 52: 1343-50. PMID 18346819 DOI: 10.1016/j.neuint.2008.02.002  1
2008 Briand LA, Flagel SB, Garcia-Fuster MJ, Watson SJ, Akil H, Sarter M, Robinson TE. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2969-80. PMID 18305460 DOI: 10.1038/npp.2008.18  1
2008 Sarter M. The substantia innominata remains incognita: pressing research themes on basal forebrain neuroanatomy. Brain Structure & Function. 213: 11-5. PMID 18183419 DOI: 10.1007/s00429-007-0165-x  1
2008 Martinez V, Sarter M. Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2635-47. PMID 18094665 DOI: 10.1038/sj.npp.1301661  1
2007 Parikh V, Kozak R, Martinez V, Sarter M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron. 56: 141-54. PMID 17920021 DOI: 10.1016/j.neuron.2007.08.025  1
2007 Briand LA, Gritton H, Howe WM, Young DA, Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Progress in Neurobiology. 83: 69-91. PMID 17681661 DOI: 10.1016/j.pneurobio.2007.06.007  1
2007 Brooks JM, Sarter M, Bruno JP. D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology. 53: 455-63. PMID 17681559 DOI: 10.1016/j.neuropharm.2007.06.006  1
2007 Sarter M. Cholinergic control of attention to cues guiding established performance versus learning: theoretical comment on Maddux, Kerfoot, Chatterjee, and Holland (2007). Behavioral Neuroscience. 121: 233-5. PMID 17324069 DOI: 10.1037/0735-7044.121.1.233  1
2007 Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2074-86. PMID 17299502 DOI: 10.1038/sj.npp.1301352  1
2007 Sarter M, Bruno JP, Parikh V. Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1452-61. PMID 17164812 DOI: 10.1038/sj.npp.1301285  1
2007 Zmarowski A, Sarter M, Bruno JP. Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release. Synapse (New York, N.Y.). 61: 115-23. PMID 17146770 DOI: 10.1002/syn.20354  1
2006 Broussard J, Sarter M, Givens B. Neuronal correlates of signal detection in the posterior parietal cortex of rats performing a sustained attention task. Neuroscience. 143: 407-17. PMID 17045755 DOI: 10.1016/j.neuroscience.2006.08.030  1
2006 Sarter M, Bruno JP, Parikh V, Martinez V, Kozak R, Richards JB. Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia. Exs. 98: 65-86. PMID 17019883  1
2006 Sarter M. Preclinical research into cognition enhancers. Trends in Pharmacological Sciences. 27: 602-8. PMID 16997388 DOI: 10.1016/j.tips.2006.09.004  1
2006 Sarter M. The consequences of atheoretical, task-driven experimentation: theoretical comment on Paban, Chambon, Jaffard, and Alescio-Lautier (2005). Behavioral Neuroscience. 120: 493-5. PMID 16719713 DOI: 10.1037/0735-7044.120.2.493  1
2006 Parikh V, Apparsundaram S, Kozak R, Richards JB, Sarter M. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Neuroscience. 141: 379-89. PMID 16675138 DOI: 10.1016/j.neuroscience.2006.03.055  1
2006 Parikh V, Sarter M. Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. Journal of Neurochemistry. 97: 488-503. PMID 16539662 DOI: 10.1111/j.1471-4159.2006.03766.x  1
2006 Sarter M, Gehring WJ, Kozak R. More attention must be paid: the neurobiology of attentional effort. Brain Research Reviews. 51: 145-60. PMID 16530842 DOI: 10.1016/j.brainresrev.2005.11.002  1
2006 Kozak R, Bruno JP, Sarter M. Augmented prefrontal acetylcholine release during challenged attentional performance. Cerebral Cortex (New York, N.Y. : 1991). 16: 9-17. PMID 15788700 DOI: 10.1093/cercor/bhi079  1
2005 Zmarowski A, Sarter M, Bruno JP. NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. The European Journal of Neuroscience. 22: 1731-40. PMID 16197513 DOI: 10.1111/j.1460-9568.2005.04333.x  1
2005 Craft TK, Mahoney JH, Devries AC, Sarter M. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance. The European Journal of Neuroscience. 21: 3117-32. PMID 15978021 DOI: 10.1111/j.1460-9568.2005.04136.x  1
2005 Sarter M, Nelson CL, Bruno JP. Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophrenia Bulletin. 31: 117-38. PMID 15888431 DOI: 10.1093/schbul/sbi006  1
2005 Martinez V, Parikh V, Sarter M. Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biological Psychiatry. 57: 1138-46. PMID 15866553 DOI: 10.1016/j.biopsych.2005.02.005  1
2005 Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M. Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3851-6. PMID 15829637 DOI: 10.1523/JNEUROSCI.0205-05.2005  1
2005 Nelson CL, Sarter M, Bruno JP. Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex. Neuroscience. 132: 347-59. PMID 15802188 DOI: 10.1016/j.neuroscience.2004.12.007  1
2005 Sarter M, Hasselmo ME, Bruno JP, Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Research. Brain Research Reviews. 48: 98-111. PMID 15708630 DOI: 10.1016/j.brainresrev.2004.08.006  1
2005 Sarter M, Parikh V. Choline transporters, cholinergic transmission and cognition. Nature Reviews. Neuroscience. 6: 48-56. PMID 15611726 DOI: 10.1038/nrn1588  1
2005 Sarter M, Bruno JP. 192 IgG-saporin-induced partial cortical cholinergic deafferentation as a model for determining the interactions between brain aging and neurodevelopmental defects in the cortical cholinergic input system Molecular Neurosurgery With Targeted Toxins. 87-100. DOI: 10.1007/978-1-59259-896-0_5  1
2004 Knox D, Sarter M, Berntson GG. Visceral afferent bias on cortical processing: role of adrenergic afferents to the basal forebrain cholinergic system. Behavioral Neuroscience. 118: 1455-9. PMID 15598156 DOI: 10.1037/0735-7044.118.6.1455  1
2004 Sarter M. Animal cognition: defining the issues. Neuroscience and Biobehavioral Reviews. 28: 645-50. PMID 15555674 DOI: 10.1016/j.neubiorev.2004.09.005  1
2004 Martinez V, Sarter M. Lateralized attentional functions of cortical cholinergic inputs. Behavioral Neuroscience. 118: 984-91. PMID 15506881 DOI: 10.1037/0735-7044.118.5.984  1
2004 Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP. Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. The European Journal of Neuroscience. 20: 1545-54. PMID 15355321 DOI: 10.1111/j.1460-9568.2004.03614.x  1
2004 Sarter M, Bruno JP. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiology of Aging. 25: 1127-39. PMID 15312959 DOI: 10.1016/j.neurobiolaging.2003.11.011  1
2004 Neigh GN, Arnold HM, Rabenstein RL, Sarter M, Bruno JP. Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release. Neuroscience. 123: 635-45. PMID 14706776 DOI: 10.1016/j.neuroscience.2003.10.006  1
2004 Sarter M, Berntson GG. Underconstrained thalamic activation + underconstrained top-down modulation of cortical input processing = underconstrained perceptions Behavioral and Brain Sciences. 27: 803-804. DOI: 10.1017/S0140525X04390187  1
2004 Sarter M, Sutherland R. Neurobiology of cognition in laboratory animals: Challenges and opportunities Neuroscience and Biobehavioral Reviews. 28: 643. DOI: 10.1016/j.neubiorev.2004.09.008  1
2003 Arnold HM, Bruno JP, Sarter M. Assessment of sustained and divided attention in rats. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.5E. PMID 18428586 DOI: 10.1002/0471142301.ns0805es22  1
2003 Berntson GG, Sarter M, Cacioppo JT. Ascending visceral regulation of cortical affective information processing. The European Journal of Neuroscience. 18: 2103-9. PMID 14622171 DOI: 10.1046/j.1460-9568.2003.02967.x  1
2003 Sarter M, Bruno JP, Givens B. Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiology of Learning and Memory. 80: 245-56. PMID 14521867 DOI: 10.1016/S1074-7427(03)00070-4  1
2003 Herzog CD, Nowak KA, Sarter M, Bruno JP. Microdialysis without acetylcholinesterase inhibition reveals an age-related attenuation in stimulated cortical acetylcholine release. Neurobiology of Aging. 24: 861-3. PMID 12927768 DOI: 10.1016/S0197-4580(02)00226-9  1
2003 Berntson GG, Shafi R, Knox D, Sarter M. Blockade of epinephrine priming of the cerebral auditory evoked response by cortical cholinergic deafferentation. Neuroscience. 116: 179-86. PMID 12535951 DOI: 10.1016/S0306-4522(02)00702-9  1
2003 Arnold HM, Nelson CL, Sarter M, Bruno JP. Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats. Psychopharmacology. 165: 346-58. PMID 12454730 DOI: 10.1007/s00213-002-1260-6  1
2002 Berntson GG, Shafi R, Sarter M. Specific contributions of the basal forebrain corticopetal cholinergic system to electroencephalographic activity and sleep/waking behaviour. The European Journal of Neuroscience. 16: 2453-61. PMID 12492440 DOI: 10.1046/j.1460-9568.2002.02310.x  1
2002 Neigh-McCandless G, Kravitz BA, Sarter M, Bruno JP. Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens. The European Journal of Neuroscience. 16: 1259-66. PMID 12405986 DOI: 10.1046/j.1460-9568.2002.02201.x  1
2002 Sarter M, Bruno JP. Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data. Annals of Neurology. 52: 384-5. PMID 12205659 DOI: 10.1002/ana.10308  1
2002 Arnold HM, Burk JA, Hodgson EM, Sarter M, Bruno JP. Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience. 114: 451-60. PMID 12204214 DOI: 10.1016/S0306-4522(02)00292-0  1
2002 Sarter M, Bruno JP. The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections. The European Journal of Neuroscience. 15: 1867-73. PMID 12099892 DOI: 10.1046/j.1460-9568.2002.02004.x  1
2002 Nelson CL, Burk JA, Bruno JP, Sarter M. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology. 161: 168-79. PMID 11981597 DOI: 10.1007/s00213-002-1004-7  1
2002 Burk JA, Herzog CD, Porter MC, Sarter M. Interactions between aging and cortical cholinergic deafferentation on attention. Neurobiology of Aging. 23: 467-77. PMID 11959409 DOI: 10.1016/S0197-4580(01)00315-3  1
2002 Sarter M, Turchi J. Age- and dementia-associated impairments in divided attention: psychological constructs, animal models, and underlying neuronal mechanisms. Dementia and Geriatric Cognitive Disorders. 13: 46-58. PMID 11731715 DOI: 10.1159/000048633  1
2002 Nutt DJ, Sarter M, Bailey J. A new vision for the Journal of Psychopharmacology Journal of Psychopharmacology. 16: 3.  1
2001 Himmelheber AM, Sarter M, Bruno JP. The effects of manipulations of attentional demand on cortical acetylcholine release. Brain Research. Cognitive Brain Research. 12: 353-70. PMID 11689296 DOI: 10.1016/S0926-6410(01)00064-7  1
2001 Burk JA, Sarter M. Dissociation between the attentional functions mediated via basal forebrain cholinergic and GABAergic neurons. Neuroscience. 105: 899-909. PMID 11530228 DOI: 10.1016/S0306-4522(01)00233-0  1
2001 Turchi J, Sarter M. Antisense oligodeoxynucleotide-induced suppression of basal forebrain NMDA-NR1 subunits selectively impairs visual attentional performance in rats. The European Journal of Neuroscience. 14: 103-17. PMID 11488954 DOI: 10.1046/j.0953-816X.2001.01610.x  1
2001 Sarter M, Bruno JP, Berntson GG. Psychotogenic properties of benzodiazepine receptor inverse agonists. Psychopharmacology. 156: 1-13. PMID 11465627 DOI: 10.1007/s002130100756  1
2001 Turchi J, Sarter M. Bidirectional modulation of basal forebrain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience. 104: 407-17. PMID 11377844 DOI: 10.1016/S0306-4522(01)00089-6  1
2001 Sarter M, Givens B, Bruno JP. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Research. Brain Research Reviews. 35: 146-60. PMID 11336780 DOI: 10.1016/S0165-0173(01)00044-3  1
2001 Neigh GN, Arnold HM, Sarter M, Bruno JP. Dissociations between the effects of intra-accumbens administration of amphetamine and exposure to a novel environment on accumbens dopamine and cortical acetylcholine release. Brain Research. 894: 354-8. PMID 11251215 DOI: 10.1016/S0006-8993(01)02059-5  1
2001 Arnold HM, Fadel J, Sarter M, Bruno JP. Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain. Brain Research. 894: 74-87. PMID 11245817 DOI: 10.1016/S0006-8993(00)03328-X  1
2001 Fadel J, Sarter M, Bruno JP. Basal forebrain glutamatergic modulation of cortical acetylcholine release. Synapse (New York, N.Y.). 39: 201-12. PMID 11169769 DOI: 10.1002/1098-2396(20010301)39:3<201::AID-SYN1001>3.0.CO;2-3  1
2000 Turchi J, Sarter M. Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance. The European Journal of Neuroscience. 12: 4505-14. PMID 11122361 DOI: 10.1046/j.1460-9568.2000.01347.x  1
2000 Sarter M, Podell M. Preclinical psychopharmacology of AIDS-associated dementia: lessons to be learned from the cognitive psychopharmacology of other dementias. Journal of Psychopharmacology (Oxford, England). 14: 197-204. PMID 11106297  1
2000 Himmelheber AM, Bruno JP, Sarter M. Effects of intra-accumbens infusions of amphetamine or cis-flupenthixol on sustained attention performance in rats. Behavioural Brain Research. 116: 123-33. PMID 11080543 DOI: 10.1016/S0166-4328(00)00266-7  1
2000 Nelson CL, Sarter M, Bruno JP. Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release. Psychopharmacology. 151: 406-15. PMID 11026747 DOI: 10.1007/s002130000494  1
2000 McGaughy J, Everitt BJ, Robbins TW, Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behavioural Brain Research. 115: 251-63. PMID 11000424 DOI: 10.1016/S0166-4328(00)00262-X  1
2000 Bushnell PJ, Levin ED, Marrocco RT, Sarter MF, Strupp BJ, Warburton DM. Attention as a target of intoxication: insights and methods from studies of drug abuse. Neurotoxicology and Teratology. 22: 487-502. PMID 10974587 DOI: 10.1016/S0892-0362(00)00077-5  1
2000 Stowell JR, Berntson GG, Sarter M. Attenuation of the bidirectional effects of chlordiazepoxide and FG 7142 on conditioned response suppression and associated cardiovascular reactivity by loss of cortical cholinergic inputs. Psychopharmacology. 150: 141-9. PMID 10907667 DOI: 10.1007/s002130000443  1
2000 Gill TM, Sarter M, Givens B. Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4745-57. PMID 10844044  1
2000 Himmelheber AM, Sarter M, Bruno JP. Increases in cortical acetylcholine release during sustained attention performance in rats. Brain Research. Cognitive Brain Research. 9: 313-25. PMID 10808142 DOI: 10.1016/S0926-6410(00)00012-4  1
2000 Arnold HM, Nelson CL, Neigh GN, Sarter M, Bruno JP. Systemic and intra-accumbens administration of amphetamine differentially affects cortical acetylcholine release. Neuroscience. 96: 675-85. PMID 10727786 DOI: 10.1016/S0306-4522(99)00590-4  1
2000 Sarter M, Bruno JP, Miner LA, McGaughy J. Development of a method for intraparenchymal infusions of 192 IgG-saporin: a comment on Pizzo et al. (1999) Journal of Neuroscience Methods. 96: 169-70. PMID 10720682 DOI: 10.1016/S0165-0270(99)00196-X  1
2000 Sarter M, Bruno JP. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience. 95: 933-52. PMID 10682701 DOI: 10.1016/S0306-4522(99)00487-X  1
1999 McGaughy J, Sarter M. Effects of ovariectomy, 192 IgG-saporin-induced cortical cholinergic deafferentation, and administration of estradiol on sustained attention performance in rats. Behavioral Neuroscience. 113: 1216-32. PMID 10636300 DOI: 10.1037//0735-7044.113.6.1216  1
1999 Hart S, Sarter M, Berntson GG. Cholinergic inputs to the rat medial prefrontal cortex mediate potentiation of the cardiovascular defensive response by the anxiogenic benzodiazephine receptor partial inverse agonist FG 7142. Neuroscience. 94: 1029-38. PMID 10625045 DOI: 10.1016/S0306-4522(99)00269-9  1
1999 Sarter M, Bruno JP, Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Annals of the New York Academy of Sciences. 877: 368-82. PMID 10415659 DOI: 10.1111/j.1749-6632.1999.tb09277.x  1
1999 McGaughy J, Decker MW, Sarter M. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology. 144: 175-82. PMID 10394999 DOI: 10.1007/s002130050991  1
1999 Sarter M, Berntson GG. Tapping artificially into natural talents. Trends in Neurosciences. 22: 300-2. PMID 10370269 DOI: 10.1016/S0166-2236(99)01419-8  1
1999 Moore H, Fadel J, Sarter M, Bruno JP. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience. 88: 811-22. PMID 10363819 DOI: 10.1016/S0306-4522(98)00261-9  1
1999 Bruno JP, Sarter M, Moore Arnold H, Himmelheber AM. In vivo neurochemical correlates of cognitive processes: methodological and conceptual challenges. Reviews in the Neurosciences. 10: 25-48. PMID 10356990  1
1999 Steigerwald ES, Sarter M, March P, Podell M. Effects of feline immunodeficiency virus on cognition and behavioral function in cats. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 20: 411-9. PMID 10225221  1
1999 Fadel J, Sarter M, Bruno JP. Age-related attenuation of stimulated cortical acetylcholine release in basal forebrain-lesioned rats. Neuroscience. 90: 793-802. PMID 10218780 DOI: 10.1016/S0306-4522(98)00515-6  1
1999 Sarter M, Bruno JP. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends in Neurosciences. 22: 67-74. PMID 10092046 DOI: 10.1016/S0166-2236(98)01289-2  1
1999 Miner LA, Sarter M. Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. Brain Research. Cognitive Brain Research. 7: 269-83. PMID 9838159 DOI: 10.1016/S0926-6410(98)00030-5  1
1998 McGaughy J, Sarter M. Sustained attention performance in rats with intracortical infusions of 192 IgG-saporin-induced cortical cholinergic deafferentation: effects of physostigmine and FG 7142. Behavioral Neuroscience. 112: 1519-25. PMID 9926833 DOI: 10.1037/0735-7044.112.6.1519  1
1998 Sarter M, Bruno JP. Cortical acetylcholine, reality distortion, schizophrenia, and Lewy Body Dementia: too much or too little cortical acetylcholine? Brain and Cognition. 38: 297-316. PMID 9841788 DOI: 10.1006/brcg.1998.1035  1
1998 Sarter M, McGaughy J. Assessment of sustained and divided attention in rats: aspects of validity; [comment]. Psychopharmacology. 138: 260-2; discussion 26. PMID 9725747 DOI: 10.1007/s002130050669  1
1998 Berntson GG, Sarter M, Cacioppo JT. Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link. Behavioural Brain Research. 94: 225-48. PMID 9722275 DOI: 10.1016/S0166-4328(98)00041-2  1
1998 Himmelheber AM, Fadel J, Sarter M, Bruno JP. Effects of local cholinesterase inhibition on acetylcholine release assessed simultaneously in prefrontal and frontoparietal cortex. Neuroscience. 86: 949-57. PMID 9692730 DOI: 10.1016/S0306-4522(98)00097-9  1
1998 Deller T, Sarter M. Effects of repeated administration of amphetamine on behavioral vigilance: evidence for "sensitized" attentional impairments. Psychopharmacology. 137: 410-4. PMID 9676902 DOI: 10.1007/s002130050637  1
1998 Sarter M, Bruno JP. Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable. Brain Research. Brain Research Reviews. 27: 143-56. PMID 9622614 DOI: 10.1016/S0165-0173(98)00003-4  1
1998 Fieldstone A, Zipf WB, Sarter MF, Berntson GG. Food intake in Prader-Willi syndrome and controls with obesity after administration of a benzodiazepine receptor agonist. Obesity Research. 6: 29-33. PMID 9526967 DOI: 10.1002/j.1550-8528.1998.tb00311.x  0.52
1998 Hart S, Sarter M, Berntson GG. Cardiovascular and somatic startle and defense: concordant and discordant actions of benzodiazepine receptor agonists and inverse agonists. Behavioural Brain Research. 90: 175-86. PMID 9521549 DOI: 10.1016/S0166-4328(97)00097-1  1
1997 Turchi J, Sarter M. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Brain Research. Cognitive Brain Research. 6: 147-58. PMID 9450608 DOI: 10.1016/S0926-6410(97)00027-X  1
1997 Sarter M, Bruno JP. Dopamine role. Science (New York, N.Y.). 278: 1549-50. PMID 9411770  1
1997 Himmelheber AM, Sarter M, Bruno JP. Operant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli. Brain Research. Cognitive Brain Research. 6: 23-36. PMID 9395847 DOI: 10.1016/S0926-6410(97)00014-1  1
1997 Miner LA, Ostrander M, Sarter M. Effects of ibotenic acid-induced loss of neurons in the medial prefrontal cortex of rats on behavioral vigilance: evidence for executive dysfunction. Journal of Psychopharmacology (Oxford, England). 11: 169-78. PMID 9208380 DOI: 10.1177/026988119701100210  1
1997 McGaughy J, Sandstrom M, Ruland S, Bruno JP, Sarter M. Lack of effects of lesions of the dorsal noradrenergic bundle on behavioral vigilance. Behavioral Neuroscience. 111: 646-52. PMID 9189279 DOI: 10.1037/0735-7044.111.3.646  1
1997 Berntson GG, Hart S, Sarter M. The cardiovascular startle response: anxiety and the benzodiazepine receptor complex. Psychophysiology. 34: 348-57. PMID 9175449 DOI: 10.1111/j.1469-8986.1997.tb02405.x  1
1997 Givens B, Sarter M. Modulation of cognitive processes by transsynaptic activation of the basal forebrain. Behavioural Brain Research. 84: 1-22. PMID 9079768 DOI: 10.1016/S0166-4328(96)00146-5  1
1997 Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Research. Brain Research Reviews. 23: 28-46. PMID 9063585 DOI: 10.1016/S0165-0173(96)00009-4  1
1997 Sarter M, Bruno JP. Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers. Behavioural Brain Research. 83: 7-14. PMID 9062654 DOI: 10.1016/S0166-4328(97)86039-1  1
1997 Gray FA, Young AMJ, Joseph MH, Sarter M, Bruno JP. Dopamine's role [2] (multiple letters) Science. 278: 1549-1550.  1
1996 Berntson G, Sarter M, Ruland S, Hart S, Ronis V. Benzodiazepine receptor agonists and inverse agonists yield concordant rather than opposing effects on startle responses. Journal of Psychopharmacology (Oxford, England). 10: 309-12. PMID 22302979 DOI: 10.1177/026988119601000409  1
1996 Mar CM, Smith DA, Sarter M. Behavioural vigilance in schizophrenia. Evidence for hyperattentional processing. The British Journal of Psychiatry : the Journal of Mental Science. 169: 781-9. PMID 8968639  1
1996 Sandstrom MI, Sarter M, Bruno JP. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates. Brain Research. Developmental Brain Research. 96: 148-58. PMID 8922677 DOI: 10.1016/0165-3806(96)00103-4  1
1996 Sarter M, Berntson GG, Bruno JP, Givens BS. Agonizing over antagonizing: what do benzodiazepine receptor antagonists demonstrate? Psychopharmacology. 126: 182-4. PMID 8856839 DOI: 10.1007/BF02246355  1
1996 Berntson GG, Hart S, Ruland S, Sarter M. A central cholinergic link in the cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142. Behavioural Brain Research. 74: 91-103. PMID 8851918 DOI: 10.1016/0166-4328(95)00166-2  1
1996 Moore H, Stuckman S, Sarter M, Bruno JP. Potassium, but not atropine-stimulated cortical acetylcholine efflux, is reduced in aged rats. Neurobiology of Aging. 17: 565-71. PMID 8832631 DOI: 10.1016/S0197-4580(96)00075-9  1
1996 Fadel J, Moore H, Sarter M, Bruno JP. Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6592-600. PMID 8815935  1
1996 Sarter M, Bruno JP, Givens B, Moore H, McGaughy J, McMahon K. Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable. Brain Research. Cognitive Brain Research. 3: 329-43. PMID 8806034 DOI: 10.1016/0926-6410(96)00018-3  1
1996 McGaughy J, Kaiser T, Sarter M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behavioral Neuroscience. 110: 247-65. PMID 8731052 DOI: 10.1037/0735-7044.110.2.247  1
1996 Turchi J, Holley LA, Sarter M. Effects of benzodiazepine receptor inverse agonists and nicotine on behavioral vigilance in senescent rats. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: B225-31. PMID 8630700  1
1996 Sarter M, Berntson GG, Cacioppo JT. Brain imaging and cognitive neuroscience. Toward strong inference in attributing function to structure. The American Psychologist. 51: 13-21. PMID 8585670 DOI: 10.1037/0003-066X.51.1.13  1
1995 Moore H, Stuckman S, Sarter M, Bruno JP. Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling. Synapse (New York, N.Y.). 21: 324-31. PMID 8869162 DOI: 10.1002/syn.890210407  1
1995 McGaughy J, Sarter M. Effects of chlordiazepoxide and scopolamine, but not aging, on the detection and identification of conditional visual stimuli. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 50: B90-6. PMID 7874585  1
1995 McGaughy J, Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology. 117: 340-57. PMID 7770610 DOI: 10.1007/BF02246109  1
1995 Sarter M, Bushnell PJ. Testing vigilance: validity, reliability and sensitivity in methods development. Psychopharmacology. 118: 219-22. PMID 7617811 DOI: 10.1007/BF02245843  1
1995 Turchi J, Holley LA, Sarter M. Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology. 118: 195-205. PMID 7617808 DOI: 10.1007/BF02245840  1
1995 Moore H, Sarter M, Bruno JP. Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain. Neuroscience Letters. 189: 31-4. PMID 7603619 DOI: 10.1016/0304-3940(95)11444-2  1
1995 Holley LA, Turchi J, Apple C, Sarter M. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacology. 120: 99-108. PMID 7480541 DOI: 10.1007/BF02246150  1
1994 Dudchenko P, Gordon BM, Sarter M. Effects of benzodiazepine receptor ligands on simultaneous visual discriminations of variable difficulty. Journal of Psychopharmacology (Oxford, England). 8: 141-7. PMID 22298580 DOI: 10.1177/026988119400800301  1
1994 Quigley KS, Sarter MF, Hart SL, Berntson GG. Cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142 in rats. Behavioural Brain Research. 62: 11-20. PMID 7917029 DOI: 10.1016/0166-4328(94)90033-7  1
1994 Holley LA, Wiley RG, Lappi DA, Sarter M. Cortical cholinergic deafferentation following the intracortical infusion of 192 IgG-saporin: a quantitative histochemical study. Brain Research. 663: 277-86. PMID 7874512 DOI: 10.1016/0006-8993(94)91274-2  1
1994 McGaughy J, Turchi J, Sarter M. Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine. Psychopharmacology. 115: 213-20. PMID 7862897 DOI: 10.1007/BF02244774  1
1994 Sarter M. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology. 114: 539-50. PMID 7855215 DOI: 10.1007/BF02244983  1
1994 Sarter MF, Bruno JP. Cognitive functions of cortical ACh: lessons from studies on trans-synaptic modulation of activated efflux. Trends in Neurosciences. 17: 217-21. PMID 7521080 DOI: 10.1016/0166-2236(94)90001-9  1
1993 Holley LA, Miller JA, Chmielewski PA, Dudchenko P, Sarter M. Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission. Brain Research. 610: 181-93. PMID 8391369 DOI: 10.1016/0006-8993(93)91399-D  1
1993 Moore H, Sarter M, Bruno JP. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Research. 627: 267-74. PMID 8298971 DOI: 10.1016/0006-8993(93)90330-P  1
1992 Dudchenko P, Sarter M. Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide. Psychopharmacology. 107: 263-70. PMID 1615125 DOI: 10.1007/BF02245146  1
1992 Sarter M, Hagan J, Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacology. 107: 144-59. PMID 1615119 DOI: 10.1007/BF02245132  1
1992 Sarter M, Hagan J, Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II. Psychopharmacology. 107: 461-73. PMID 1603889 DOI: 10.1007/BF02245257  1
1992 Moore H, Dudchenko P, Comer KS, Bruno JP, Sarter M. Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives. Psychopharmacology. 108: 241-3. PMID 1410143 DOI: 10.1007/BF02245315  1
1992 Holley LA, Dudchenko P, Sarter M. Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479. Psychopharmacology. 109: 223-30. PMID 1365661 DOI: 10.1007/BF02245504  1
1992 Dudchenko P, Paul B, Sarter M. Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity. Psychopharmacology. 109: 203-11. PMID 1365658 DOI: 10.1007/BF02245501  1
1992 Moore H, Dudchenko P, Bruno JP, Sarter M. Toward modeling age-related changes of attentional abilities in rats: simple and choice reaction time tasks and vigilance. Neurobiology of Aging. 13: 759-72. PMID 1362798 DOI: 10.1016/0197-4580(92)90100-C  1
1992 Moore H, Sarter M, Bruno JP. Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain Research. 596: 17-29. PMID 1334777 DOI: 10.1016/0006-8993(92)91527-L  1
1992 Dudchenko P, Sarter M. Failure of a chlordiazepoxide to reproduce the behavioral effects of muscimol administered into the basal forebrain. Behavioural Brain Research. 47: 202-5. PMID 1317181 DOI: 10.1016/S0166-4328(05)80127-5  1
1991 Dudchenko P, Sarter M. GABAergic control of basal forebrain cholinergic neurons and memory. Behavioural Brain Research. 42: 33-41. PMID 2029342 DOI: 10.1016/S0166-4328(05)80037-3  1
1991 Sarter M, Bruno JP, Dudchenko P. Cholinergic controversies. Trends in Neurosciences. 14: 484; author reply 48. PMID 1726764  1
1991 Sarter M, Dudchenko P. Dissociative effects of ibotenic and quisqualic acid-induced basal forebrain lesions on cortical acetylcholinesterase-positive fiber density and cytochrome oxidase activity. Neuroscience. 41: 729-38. PMID 1651463 DOI: 10.1016/0306-4522(91)90363-S  1
1990 Sarter M, Bruno JP, Dudchenko P. Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology. 101: 1-17. PMID 2160662 DOI: 10.1007/BF02253710  1
1989 Kaulen P, Brüning G, Schneider HH, Sarter M, Baumgarten HG. Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram. Brain Research. 503: 229-45. PMID 2557965 DOI: 10.1016/0006-8993(89)91669-7  1
1989 Sarter M, Stephens DN. Disinhibitory properties of beta-carboline antagonists of benzodiazepine receptors: a possible therapeutic approach for senile dementia? Biochemical Society Transactions. 17: 81-3. PMID 2541035  1
1988 Sarter M, Stephens DN. Beta-carbolines as tools in memory research: animal data and speculations. Psychopharmacology Series. 6: 230-45. PMID 3064084  1
1988 Stephens DN, Sarter M, Duka T, Dorow R, Schneider HH. [New approaches in memory research. The beta-carboline substance class]. Fortschritte Der Medizin. 106: 675-6, 677. PMID 3061909  1
1988 Stephens DN, Sarter M. Bidirectional nature of benzodiazepine receptor ligands extends to effects on vigilance. Psychopharmacology Series. 6: 205-17. PMID 2851141  1
1988 Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology. 94: 491-5. PMID 2836875 DOI: 10.1007/BF00212843  1
1988 Sarter M, Schneider HH, Stephens DN. Treatment strategies for senile dementia: antagonist beta-carbolines. Trends in Neurosciences. 11: 13-7. PMID 2469147 DOI: 10.1016/0166-2236(88)90042-2  1
1987 Jensen LH, Stephens DN, Sarter M, Petersen EN. Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain Research Bulletin. 19: 359-64. PMID 3676858 DOI: 10.1016/0361-9230(87)90104-3  1
1985 Stephens DN, Weidmann R, Quartermain D, Sarter M. Reversal learning in senescent rats. Behavioural Brain Research. 17: 193-202. PMID 4084391 DOI: 10.1016/0166-4328(85)90043-9  1
1985 Sarter M, Markowitsch HJ. Involvement of the amygdala in learning and memory: a critical review, with emphasis on anatomical relations. Behavioral Neuroscience. 99: 342-80. PMID 3939663  1
1985 Sarter M, Markowitsch HJ. The amygdala's role in human mnemonic processing. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 21: 7-24. PMID 3886288  1
1985 Sarter M, Markowitsch HJ. Collateralization in the mammalian nervous system. The International Journal of Neuroscience. 28: 215-34. PMID 2419271  1
1985 Sarter M, Markowitsch HJ. Convergence of intra- and interhemispheric cortical afferents: lack of collateralization and evidence for a subrhinal cell group projecting heterotopically. The Journal of Comparative Neurology. 236: 283-96. PMID 2414334 DOI: 10.1002/cne.902360302  1
1984 Sarter M, Markowitsch HJ. Collateral innervation of the medial and lateral prefrontal cortex by amygdaloid, thalamic, and brain-stem neurons. The Journal of Comparative Neurology. 224: 445-60. PMID 6715589 DOI: 10.1002/cne.902240312  1
1984 Irle E, Sarter M, Guldin WO, Markowitsch HJ. Afferents to the ventral tegmental nucleus of Gudden in the mouse, rat, and cat. The Journal of Comparative Neurology. 228: 509-41. PMID 6436341 DOI: 10.1002/cne.902280406  1
1983 Sarter M, Markowitsch HJ. Convergence of basolateral amygdaloid and mediodorsal thalamic projections in different areas of the frontal cortex in the rat. Brain Research Bulletin. 10: 607-22. PMID 6871734  1
1983 Sarter M, Markowitsch HJ. Reduced resistance to progressive extinction in senescent rats: a neuroanatomical and behavioral study. Neurobiology of Aging. 4: 203-15. PMID 6669192  1
1983 Pritzel M, Huston JP, Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience. 9: 879-88. PMID 6413887  0.84
1983 Pritzel M, Sarter M, Morgan S, Huston JP. Interhemispheric nigrostriatal projections in the rat: bifurcating nigral projections and loci of crossing in the diencephalon. Brain Research Bulletin. 10: 385-90. PMID 6189566  0.84
Show low-probability matches.